Immune marker changes and risk of multiple myeloma: a nested case-control study using repeated pre-diagnostic blood samples | Haematologica
![Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study | Blood Cancer Journal Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study | Blood Cancer Journal](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41408-022-00732-3/MediaObjects/41408_2022_732_Fig1_HTML.png)
Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study | Blood Cancer Journal
![A phase I study of anti‐BCMA CAR T cell therapy in relapsed/refractory multiple myeloma and plasma cell leukemia - Li - 2021 - Clinical and Translational Medicine - Wiley Online Library A phase I study of anti‐BCMA CAR T cell therapy in relapsed/refractory multiple myeloma and plasma cell leukemia - Li - 2021 - Clinical and Translational Medicine - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/d0668b16-6f13-4a1b-99c6-7416a2f7b1b3/ctm2346-fig-0002-m.jpg)
A phase I study of anti‐BCMA CAR T cell therapy in relapsed/refractory multiple myeloma and plasma cell leukemia - Li - 2021 - Clinical and Translational Medicine - Wiley Online Library
![Targets of biologic disease‐modifying antirheumatic drugs and risk of multiple myeloma - Calip - 2020 - International Journal of Cancer - Wiley Online Library Targets of biologic disease‐modifying antirheumatic drugs and risk of multiple myeloma - Calip - 2020 - International Journal of Cancer - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/a492ce03-a6ef-4a63-b0c4-d6679a05c75b/ijc.v147.5.cover.jpg?trick=1677628964568)
Targets of biologic disease‐modifying antirheumatic drugs and risk of multiple myeloma - Calip - 2020 - International Journal of Cancer - Wiley Online Library
![Cureus | Rhabdomyolysis and Acute Renal Dysfunction as Initial Manifestations of Monoclonal Gammopathy of Renal Significance | Article Cureus | Rhabdomyolysis and Acute Renal Dysfunction as Initial Manifestations of Monoclonal Gammopathy of Renal Significance | Article](https://assets.cureus.com/uploads/figure/file/538389/lightbox_c8016ac09d1a11ed945b4115e58945c7-cureus.png)
Cureus | Rhabdomyolysis and Acute Renal Dysfunction as Initial Manifestations of Monoclonal Gammopathy of Renal Significance | Article
Clinical outcomes of bortezomib-based therapy in Taiwanese patients with multiple myeloma: A nationwide population-based study and a single-institute analysis | PLOS ONE
![Frontiers | Real World Experience of Daratumumab: Evaluating Lymphopenia and Adverse Events in Multiple Myeloma Patients Frontiers | Real World Experience of Daratumumab: Evaluating Lymphopenia and Adverse Events in Multiple Myeloma Patients](https://www.frontiersin.org/files/Articles/575168/fonc-10-575168-HTML/image_m/fonc-10-575168-g001.jpg)
Frontiers | Real World Experience of Daratumumab: Evaluating Lymphopenia and Adverse Events in Multiple Myeloma Patients
![Getting the Most Out of Your Treatment: Your Role in Achieving Desired Outcomes in the Patient Journey - CONQUER: the patient voice Getting the Most Out of Your Treatment: Your Role in Achieving Desired Outcomes in the Patient Journey - CONQUER: the patient voice](https://conquer-magazine.com/images/special_issues/2021/November/table-1.png)
Getting the Most Out of Your Treatment: Your Role in Achieving Desired Outcomes in the Patient Journey - CONQUER: the patient voice
![Genetic regulation of serum IgA levels and susceptibility to common immune, infectious, kidney, and cardio-metabolic traits | Nature Communications Genetic regulation of serum IgA levels and susceptibility to common immune, infectious, kidney, and cardio-metabolic traits | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-022-34456-6/MediaObjects/41467_2022_34456_Fig1_HTML.png)
Genetic regulation of serum IgA levels and susceptibility to common immune, infectious, kidney, and cardio-metabolic traits | Nature Communications
![JCM | Free Full-Text | Weight-Based Bisphosphonate Administration for Multiple Myeloma Patients and the Risks of Skeletal Complications JCM | Free Full-Text | Weight-Based Bisphosphonate Administration for Multiple Myeloma Patients and the Risks of Skeletal Complications](https://www.mdpi.com/jcm/jcm-12-01637/article_deploy/html/images/jcm-12-01637-g001.png)